Connect with us

Hi, what are you looking for?

Jewish Business News

Financial Research

Jim Cramer’s Speculation Propels Jack in The Box to Yearly High

Jack in The Box

Jack in the Box Inc. popped to a new high for the year after Jim Cramer, host of the hit CNBC show “Mad Money”, made bullish comments on the fast-food purveyor, financial media outlet Benzinga said.

Cramer, speaking on CNBC, said Jack in the Box could split off its comparatively fast-growing Qdoba Mexican Grill as an independent company, the report said.

Jack in the Box, up about 61 percent year-to-date, changed hands recently at $80.41, up 1.5 percent, Benzinga said.

“I could see someone taking a stake and asking that the company divided in two and the company agrees, ” Cramer said. “If they took the next step and divided it into Qdoba and Jack in the Box, you got a hundred dollar stock and I think you’d have it probably in a week.”

Same-store sales grew 2 percent in fiscal 2014 for Jack in the Box restaurants and 6 percent for Qdoba. As of September 28, the Jack in the Box system included 2, 250 restaurants, of which 431 were company-operated and 1, 819 were operated as franchises.

The Qdoba system, acquired by Jack in the Box in 2003, and described by the company as the second-largest “fast-casual” Mexican restaurant chain in the United States, included 638 restaurants as of September 28. Roughly half of Qdoba restaurants are franchises.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Newsletter

Advertisement

You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...

Travel

After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

empty

The contract signed between the Israeli government and Pfizer shows clearly and unequivocally that this is a clinical study on humans - The agreement...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.

Advertisement
cialis cialis satış